Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-03 Sale |
2023-01-04 5:16 pm |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
13,639 | $0 | $0 | 0 (Direct) |
View |
| 2022-05-24 Sale |
2022-05-26 6:19 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner |
10,376,936 | $0.07234 | $750,662 | 0 (Indirect) |
View |
| 2022-04-11 Purchase |
2022-04-13 5:10 pm |
Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner |
3,580,526 | $1.9 | $6,802,999 | 3,948,948 (Indirect) |
View |
| 2021-12-10 Sale |
2021-12-27 4:41 pm |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
497,270 | $0.9944 | $494,483 | 2,563,257 (Indirect) |
View |
| 2021-10-18 Purchase |
2021-10-19 9:11 pm |
Trevi Therapeutics Inc. | TRVI | Behbahani Ali 10% Owner |
1,851,852 | $0 | $0 | 11,493,554 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 9:28 pm |
Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner |
1,944,444 | $18 | $34,999,992 | 23,983,073 (Indirect) |
View |
| 2021-06-28 Purchase |
2021-06-30 6:01 pm |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-01 Other |
2023-06-05 4:46 pm |
N/A N/A |
Arcellx Inc. | ACLX | Behbahani Ali Director |
141 | $0 | 565 (Direct) |
View |
| 2023-05-16 Option Award |
2023-05-17 9:16 pm |
N/A 2033-05-15 |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 4:41 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
7,111 | $1.67 | 3,483,872 (Direct) |
View |
| 2022-12-20 Other |
2022-12-22 6:31 pm |
N/A N/A |
Arcellx Inc. | ACLX | Behbahani Ali Director |
283 | $0 | 566 (Indirect) |
View |
| 2022-12-16 Option Award |
2022-12-19 9:27 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
7,917 | $1.5 | 3,476,761 (Direct) |
View |
| 2022-11-30 Equity Swap |
2022-12-02 5:03 pm |
N/A N/A |
Akouos Inc. | AKUS | Behbahani Ali 10% Owner |
4,294,207 | $0 | 0 (Indirect) |
View |
| 2022-09-16 Option Award |
2022-09-19 6:39 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
4,532 | $2.62 | 3,468,844 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 5:18 pm |
2023-07-01 2032-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
737,050 | $0 | 737,050 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-17 4:35 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
5,850 | $2.03 | 3,464,312 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:29 pm |
N/A 2032-06-14 |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:08 pm |
N/A N/A |
MINERVA SURGICAL INC | UTRS | Behbahani Ali Director |
49,792 | $2.41 | 58,279 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:08 pm |
N/A 2032-06-09 |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:46 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:31 pm |
N/A 2032-06-07 |
Nkarta Inc. | NKTK | Behbahani Ali Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:16 pm |
N/A 2032-06-06 |
CVRx Inc. | CVRX | Behbahani Ali Director |
26,985 | $0 | 26,985 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 4:49 pm |
N/A 2032-06-05 |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
8,932 | $0 | 18,998 (Direct) |
View |
| 2022-03-18 Option Award |
2022-03-18 4:15 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
4,346 | $3.02 | 3,458,462 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-17 4:50 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
2,472 | $5.31 | 3,454,116 (Direct) |
View |
| 2021-10-26 Conversion |
2021-10-28 9:06 pm |
N/A N/A |
MINERVA SURGICAL INC | UTRS | Behbahani Ali Director |
49,215 | $0 | 19,635 (Direct) |
View |
Ownership |
2021-10-21 8:02 pm |
N/A N/A |
MINERVA SURGICAL INC | UTRS | Behbahani Ali Director |
0 | $0 | 5,181 (Direct) |
View |
| 2021-09-17 Option Award |
2021-09-23 5:43 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
1,326 | $9.9 | 3,451,644 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:01 pm |
2022-07-01 2031-07-01 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
474,385 | $0 | 474,385 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 4:27 pm |
2022-07-01 2031-07-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Behbahani Ali Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-29 Option Award |
2021-07-01 5:35 pm |
N/A 2031-06-28 |
CVRx Inc. | CVRX | Behbahani Ali Director |
10,382 | $0 | 10,382 (Direct) |
View |
| 2021-06-28 Conversion |
2021-06-30 9:28 pm |
N/A N/A |
Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner |
93,285,104 | $0 | 23,983,073 (Indirect) |
View |
| 2021-06-28 Conversion |
2021-06-30 6:01 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
Ownership |
2021-06-29 9:32 pm |
N/A 2023-12-14 |
CVRx Inc. | CVRX | Behbahani Ali Director |
0 | $0 | 5,244 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:47 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
47,132 | $0 | 47,132 (Direct) |
View |
Ownership |
2021-06-24 9:23 pm |
N/A N/A |
Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner |
0 | $0 | 69,963,828 (Indirect) |
View |
Ownership |
2021-06-23 9:03 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
| 2021-06-18 Option Award |
2021-06-22 7:18 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
1,014 | $12.95 | 3,465,318 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 7:18 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
15,000 | $0 | 3,465,318 (Direct) |
View |
| 2021-06-13 Option Award |
2021-06-15 4:25 pm |
N/A 2031-06-12 |
Nkarta Inc. | NKTK | Behbahani Ali Director |
16,511 | $0 | 16,511 (Direct) |
View |